For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Suresh S. Ramalingam, MD, FACP, FASCO, emphasizes the role of community oncologists in translating new advancements in lung cancer research into widespread patient benefit.

If Australia's new lung cancer screening program had been around earlier, Anne Fidler thinks she might have had a lot longer ...

Among the lung cancer population with EGFR mutations, patients with insertions at exon 20 (ex20ins) represent a significant unmet need segment. These patients often have poorer outcomes compared to ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...